Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients
EEG-triggered fMRI in Epilepsy Patients
1 other identifier
interventional
2
1 country
1
Brief Summary
A prospective exploratory study in patients with drug resistant epilepsy with a target comparison of long term outcome. NeuroScan software modules and a MagLink will be used to acquire EEG in combination with MRI/fMRI data. The MagLink system is used for obtaining integrated EEG and Event Related Potential (ERP) recordings while the subject is inside the MRI machine, without compromising the raw EEG data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 10, 2014
CompletedFirst Posted
Study publicly available on registry
July 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2019
CompletedSeptember 20, 2019
September 1, 2019
6.5 years
July 10, 2014
September 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with at least 40 interictal epileptic discharges during the fMRI
1 year
Study Arms (1)
EEG Triggered fMRI using Micro Maglink
EXPERIMENTALEEG Triggered fMRI to be performed using the Micro Maglink
Interventions
Eligibility Criteria
You may qualify if:
- Refractory epilepsy cases, referred by the service of Neurology. These are cases whose pathophysiology is resistant to treatment, including change in medication and or added medication.
- Patients will be included if they agree to sign an Institutional Review Board approved written consent.
You may not qualify if:
- Patients with overt symptoms or signs of anxiety than cannot cooperate during the recording inside the scanner, unless consent is given for the procedure to be performed with sedation by the anesthesia department.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baptist Hospital
Miami, Florida, 33173, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sergio Gonzalez-Arias, MD
Baptist Health South Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2014
First Posted
July 18, 2014
Study Start
February 1, 2013
Primary Completion
July 30, 2019
Study Completion
July 30, 2019
Last Updated
September 20, 2019
Record last verified: 2019-09